Advertisement

Clinical Reviews in Allergy & Immunology

, Volume 18, Issue 3, pp 397–419 | Cite as

Clinical effects of allergen avoidance

  • Adnan Custovic
  • Ashley Woodcock
Article

Conclusions

The costs of asthma care are increasing. A successful, simple and widely applicable environmental intervention could have major benefits. Although all trials of bed coverings suggest they are clinically effective, the impact of their widespread use by asthmatics has not been determined in a public health context. In 1992, the British Society of Allergy and Clinical Immunology Working Group reviewed all the published data and, agreed on the inadequancy of avoidance trials and the need for a large-scale study on mite-allergen avoidance (97). More recently, the Third International Workshop on Indoor Allergens and Asthma stated: “There is an urgent need to develop adequately-powered, randomised, controlled studies to investigate the potential benefits of low-allergen domestic environments in patients with allergic disease. Such studies need to address compliance, cost effectiveness, be of adequate length (e.g., 12 months), and be tailored for different socio-economic groups and age groups” (98). The 1997 revision of the British Thoracic Society Asthma Guidelines states: “Support for house dust mite avoidance measures reflects a change to the 1993 Guidelines, but further research into methodology and duration of action of these measures is needed” (99). There remains an urgent need to develop a large-scale trial of the widespread applicability of miteallergen avoidance and the effect on patient symptoms, exacerbation rate, use of medication, and overall health costs. One such study on the effect of mite-allergen avoidance by the use of allergen-impermeable bedding on asthma control in adults is currently being carried out in the United Kingdom (100). This is a randomized, parallel-group, double-blind, placebo-controlled trial, with 2000 patients entering the run-in period and 1800 being randomized. During the first 6 mo of the trial (phase A) patients will take their usual inhaled steroid therapy, and during the next 6 mo (Phase B, mo 6\2-12) patients will make a controlled reduction of inhaled steroids. The results of this study will show conclusively whether a simple intervention designed to reduce domestic mite-allergen exposure can improvethe clinical control of asthma, which subgroups of patients benefit, and whether a reduction in regular inhaled steroid use can be achieved in primary-care patients.

Keywords

Asthma Allergy Clin Immunol House Dust Immunology Volume Allergen Exposure 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Dana CL. (1921), The story of a great consultation. (1921), Ann. Med History 13:122.Google Scholar
  2. 2.
    Leopold SS, Leopold, CS. (1925), Bronchial asthma and allied allergic disorders. Preliminary report of a study under controlled conditions of environment temperature and humidity. JAMA 84:731–735.Google Scholar
  3. 3.
    Storm van Leeuwen W, Einthoven W, Kremer W. (1927), The allergen proof chamber in the treatment of bronchial asthma and other respiratory diseases. Lancet i:1287–1289.CrossRefGoogle Scholar
  4. 4.
    Dekker H. (1928), Asthma und milben. Munch Med Wochenschr 75:515, 516.Google Scholar
  5. 5.
    Omenaas E, Bakke P, Eide GE, Elsayed S, Gulsvik A. (1996), Serum house dust mite antibodies: predictor of increased bronchial responsiveness in adults of a community. Eur Respir J 9:919–925.PubMedCrossRefGoogle Scholar
  6. 6.
    Burrows B, Sears MR, Flannery EM, Herbison GP, Holdaway MD. (1992), Relationship of bronchial responsiveness assessed by methacholine to serum IgE, lung function, symptoms, and diagnoses in 11-year-old New Zealand children. J Allergy Clin Immunol 90:376–385.PubMedCrossRefGoogle Scholar
  7. 7.
    Peatk JK, Tovey E, Gray EJ, Mellis CM, Woolcock A. (1994) Asthma severity and morbidity in a population sample of Sydney schoolchildren: Part II. Importance of house-dust mite allergens. Aust NZ J Med 24:270–276.Google Scholar
  8. 8.
    Burrows B, Sears MR, Flannry EM, Herbinson GP, Holdaway MD. (1995) Relations of bronchial responsiveness to allergy skin test reactivity lung function, respiratory symptoms, and diagnoses in thirteen-year-old New Zealand children. J Allergy Clin Immunol 95:548–556.PubMedCrossRefGoogle Scholar
  9. 9.
    Squillace SP, Sporik RB, Rakes G, Couture N, Lawrence A, Merriam S, et al. (1997), Sensitisation to dust mites as a dominant risk factor for asthma among adolescents living in Central Virginia. Multiple regression analysis of a population-based study Am J Respir Crit Care Med 156:1760–1764.PubMedGoogle Scholar
  10. 10.
    Tariq SM, Matthews SM, Hakim EA, Stevens M, Arshad SH, Hide DW. (1998), The prevalence of and risk factors for atopy in early childhood: a whole population birth cohort study. J Allergy Clin Immunol 101:587–593.PubMedCrossRefGoogle Scholar
  11. 11.
    Sporik R, Holgate S, Platts-Mills TAE, Cogswell J. (1990), Exposure to house dust mite allergen (Der p I) and the development of asthma in childhood. New Engl J Med 323:502–507.PubMedCrossRefGoogle Scholar
  12. 12.
    Leung R, Ho P, Lam CWK, Lai CKW. (1997), Sensitisation to inhaled allergens as a risk factor for asthma and allergic disease in Chinese population. J Allergy Clin Immunol 99:594–599.PubMedCrossRefGoogle Scholar
  13. 13.
    Duff AL, Pomeranz ES, Gelber LE, Price GW, Farris H, Hayden FG, et al. (1993), Risk factors for acute wheezing in infants and children: viruses, passive smoke, and IgE antibodies to inhalant allergens. Pediatics 92:535–540.Google Scholar
  14. 14.
    Nelson RP, DiNicolo R, Fernandez-Caldas E, Seleznick MJ, Lockey RF, Good RA. (1996), Allergen-specific IgE levels and mite allergen exposure in children with acute asthma first seen in an emergency department and in nonasthmatic, control subjects. J Allergy Clin Immunol 98:258–263.PubMedCrossRefGoogle Scholar
  15. 15.
    Sporik R, Ingram MJ, Price W, Sussman JH, Honsinger RW, Platts Mills TAE. (1995), Association of asthma with serum IgE and skin test reactivity to allergens among children living at high altitude: tickling the dragon's breath. Am J Respir Crit Care Med 151:1388–1392.PubMedGoogle Scholar
  16. 16.
    Ingram JM, Sporik R, Rose G, Honsinger R, Chapman MD, Platts-Mills TAE. (1995), Quantitative assessment of exposure to dog (Can f 1) and cat (Fed d 1) allergens: relationship to sensitisation and asthma among children living in Los Alamos, New Mexico. J Allergy Clin Immunol 96:449–456.PubMedCrossRefGoogle Scholar
  17. 17.
    Rosenstreich DL, Eggleston P, Kattan M, et al. (1997), The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among innercity children with asthma. N Engl J Med 336:1356–1363.PubMedCrossRefGoogle Scholar
  18. 18.
    Halonen M, Stern DA, Wright AL, Taussig LM, Martinez FD. (1997), Alternaria as a major allergen for asthma in children raised in a desert environment. Am J Respir Crit Care Med 155:1356–1361.PubMedGoogle Scholar
  19. 19.
    Peat JK, Tovey ER, Toelle BG, et al. (1996), House dust mite allergens: a major risk factor for childhood asthma in Australia. Am J Respir Crit Care Med 152:144–146.Google Scholar
  20. 20.
    Kuehr J, Frischer T, Meinert R, Barth R, Forster J, Schraub S, et al. (1994), Mite allergen exposure is a risk for the incidence of specific sensitization. J Allergy Clin Immunol 94:44–52.PubMedCrossRefGoogle Scholar
  21. 21.
    Dotterud LK, Van TD, Kvammen B, Dybendal T, Elsayed S, Falk ES. (1997), Allergen conten in dust from homes and schools in northern Norway in relation to sensitisation and allergy symptoms in schoolchildren. Clin Exp Allergy 27:252–261.PubMedCrossRefGoogle Scholar
  22. 22.
    Warner AM, Bjorksten B, Munir AKM, Moler C, Shou C, Kjellman NIM. (1996), Childhood asthma and exposure to indoor allergens: low mite levels are associated with sensitivity Pediatr Allergy Immunol 7:61–67.PubMedGoogle Scholar
  23. 23.
    Bjorksten F, Suoniemi I, Koski V. (1980), Neonatal birch pollen contact and subsequent allergy to birch pollen. Clin Allergy 10:581–591.Google Scholar
  24. 24.
    Warner JA, Little SA, Pollock I, Longbottom JL, Warner JO. (1991), The influence of exposure to house dust mite, cat, pollen and allergens in the homes on primary sensitisation in asthma. Pediatr Allergy Immunol 1:79–86.Google Scholar
  25. 25.
    Rowntree S Cogswell JJ, Platts-Mills TAE et al. (1985), Development of IgE and IgG antibodies to food and inhalant allergens in children at risk of atopic disease. Arch Dis Child 60:727–735.PubMedGoogle Scholar
  26. 26.
    Wahn U, Lau S, Bergmann R, Kulig M, Forster J, Bergmann K, et al. (1997), Indoor allergen exposure is a risk factor for sensitisation during the first three years of life. J Allergy Clin Immunol 99:763–769.PubMedCrossRefGoogle Scholar
  27. 27.
    Custovic A, Taggart SCO, Francis HC, Chapman MD, Woodcock A. (1996), Exposure to house dust mite allergens and the clinical activity of asthma. J Allergy Clin Immunol 98:64–72.PubMedCrossRefGoogle Scholar
  28. 28.
    Tunnicliffe W, Fletcher T, Hammond K, Roberts K, Custovic A, Simpson A, et al. Sensitivity and exposure to indoor allergens in subjects with differering asthma severity. Eur Respir J (In Press).Google Scholar
  29. 29.
    Simpson A, Custovic A, Pipis S, Adisesh A, Faragher B, Woodcock A. Exhaled nitric oxide, sensitisation and exposure to allergens in asthmatics not taking inhaled steroids. Am J Respir Crit Care Med (Submitted).Google Scholar
  30. 30.
    Strachan DP, Carey IM. (1995), Home environment and severe asthma in adolescence: a population based case-control study. Br Med J 311:53–56.Google Scholar
  31. 31.
    Kemp TJ, Siebers RW, Fischwick D, O'Grady GB, Fitzharris P, Crane J. (1996), House dust mite allergen in pillows. Br Med J 313:916.Google Scholar
  32. 32.
    Hallam C, Custovic A, Simpson B, Houghton N, Simpson, Woodcock A. (1998), House dust mite allergen in feather and synthetic pillows. Allergy 53(Suppl 43):27.Google Scholar
  33. 33.
    Nimmagadda SR, Szefler SJ, Spahn JD, Surs W, Leung DYM. (1997), Allergen exposure descreases glucocorticoid receptor binding affinity and steroid resoonsiveness in atopic asthmatics. Am J Respir Crit Care Med 155:87–93.PubMedGoogle Scholar
  34. 34.
    Munir AKM, Kjellman NIM, Bjorksten B. (1997), Exposure to indoor allergens in early infancy and sensitization. J Allergy Clin Immunol 100:177–181.PubMedCrossRefGoogle Scholar
  35. 35.
    Arshad SH, Matthews S, Gant C, Hide DW. (1992), Effects of allergen avoidance on development of allergic disorder in infancy. Lancet 339:1493–1497.PubMedCrossRefGoogle Scholar
  36. 36.
    Hide DW, Matthews S, Tariq S, Arshad SH. (1996), Allergen avoidance in infancy and allergy at 4 years of age. Allergy 51:89–93.PubMedCrossRefGoogle Scholar
  37. 37.
    Holt PJ, Sly PD. (1997), Allergic respiratory disease: strategic targets for primary prevention during childhood. Thorac 52:1–4.Google Scholar
  38. 38.
    Brown MA, Halonen MJ, Martinez FD. (1997), Cutting the cord: is birth already too late for primary prevention of allergy. Clin Exp Allergy 27:4–6.PubMedCrossRefGoogle Scholar
  39. 39.
    Jones CA, Kilburn SA, Warner JA, Warner JO. (1998), Intrauterine environment and fetal allergic sensitisation. Clin Exp Allergy 28:655–659.PubMedCrossRefGoogle Scholar
  40. 40.
    Custovic A, Smith A, Simpson B, Pipis SD, Woodcock A. (1997), Primary prevention of asthma by allergen avoidance: the effect of avoidance measures. Am J Respir Crit Care Med 155:A882.Google Scholar
  41. 41.
    van Strien RT, Praet I, Kerkhof M, Wijga A, de Jongste J, Neijens H, et al. (1997), PIAMA: framework of a study on the study on the Prevention and Incidence of Asthma and Mite Allergy. J Allergy Clin Immunol 99:S87.CrossRefGoogle Scholar
  42. 42.
    Wickman M, Korsgaard J. (1996), Transient sensitisation to house dust mites: a study on the influence of of mite exposure and sex. Allergy 51:511–513.PubMedCrossRefGoogle Scholar
  43. 43.
    Kerrebijn KF. Endogenous factors in chilhood CNSLD: methological aspects in population studies. In: Bronchitis III. Orie NGM, Van der Lende R (eds.) The Netherlands: Royal Van Gorcum Assen, 1970, pp. 38–48.Google Scholar
  44. 44.
    Platts Mills TAE, Chapman MD. (1987), Dust mites: immunology, allergic disease, and environmental control. J Allergy Clin Immunol 80:755–775.PubMedGoogle Scholar
  45. 45.
    Boner AL, Niero E, Antolini I, Valletta EA, Gaburro D. (1985), Pulmonary function and bronchial hyperreativity in asthmatic children with house dust mite allergy during prolonged stay in the Italian Alps (Misurina 1756 m). Ann Allergy 54:42–45.PubMedGoogle Scholar
  46. 46.
    Piacentini GL, Martinati L, Fornari A, Comis A, Carcereri L, Boccagni P, Boner AL. (1993), Antigen avoidance in a mountain environment: influence on basophil releasability in children with allergic asthma. J Allergy Clin Immunol 92:644–650.PubMedCrossRefGoogle Scholar
  47. 47.
    Peroni DG, Boner AL, Vallone G, Antolini I, Warner JO. (1994), Effective allergen avoidance at high altitude reduces allergen-induced bronchial hyperresponsiveness. Am J Respir Crit Care Med 149:1442–1446.PubMedGoogle Scholar
  48. 48.
    Morrison Smith J. (1981), The use of high altitude treatment for childhood asthma. Practitioner 225:1663–1666.Google Scholar
  49. 49.
    Boner AL, Peroni DG, Piacentini GL, Venge P. (1993), Influence of allergen avoidance at high altitute on serum markers of eosinophil activation in children with allergic asthma. Clin Exp Allergy 23:1021–1026.PubMedCrossRefGoogle Scholar
  50. 50.
    Simon HU, Grotzer M, Nikolaizik WH, Blaser K, Schoni MH. (1994), High altitude climate therapy reduces peripheral blood T lymphocyte activation, eosinophilia, and bronchial obstruction in children with house-dust mite allergic asthma. Pediatr Pulmonol 17:304–311.PubMedCrossRefGoogle Scholar
  51. 51.
    Valletta EA, Comis A, Del Col G, Spezia E, Boner AL. (1995), Peak expiratory flow variation and bronchial hyperresponsiveness in asthmatic children during periods of antigen avoidance and reexposure. Allergy 50:366–369.PubMedCrossRefGoogle Scholar
  52. 52.
    van Velzen E, van den Bos JW, Benckhuijsen JAW, van Essel T, de Bruijn R, Aalbers R. (1996), Effect of allergen avoidance at high altitude on direct and indirect bronchial hyperresponsiveness and markers of inflammation in children with allergic asthma. Thorax 51:582–584.PubMedGoogle Scholar
  53. 53.
    Piacentini GL, Martinati L, Mingoni S, Boner AL. (1996), Influence of allergen avoidance on the eosinophil phase of airway inflammation in children with allergic asthma. J Allergy Clin Immunol 97:1079–1084.PubMedCrossRefGoogle Scholar
  54. 54.
    Platts Mills TAE, Tovey ER, Mitchell EB, Moszoro H, Nock P, Wilkins SR. (1982). Reduction of bronchial hyperreactivity during prolonged allergen avoidance. Lancet 2:675–678.PubMedCrossRefGoogle Scholar
  55. 55.
    Gotzsche PC, Hammarquist C, Burr M. (1998), House dust mite control measures in the management of asthma: meta analysis. Br Med J 317:1105–1110.Google Scholar
  56. 56.
    Custovic A, Simpson A, Chapman MD, Woodcock A (1998), Allergen avoidance in the treatment of asthma and atopic disorders. Thorax 53:63–72.PubMedGoogle Scholar
  57. 57.
    Sarsfield JK, Gowland G, Toy R, Norman ALE. (1974), Mite sensitive asthma of childhood. Trial of avoidance measures. Arch Dis Child 49:716–721.PubMedGoogle Scholar
  58. 58.
    Burr ML, Leger ASST, Neale E. (1976), Anti-mite measures in mite-sensitive adult asthma. A controlled trial. Lancet i:333–335.CrossRefGoogle Scholar
  59. 59.
    Burr ML, Dean BV, Merrett TG, Neale E, Leger ASST, Verrier-Jones ER. (1980), Effect of anti-mite measures on children with mite-sensitive asthma: a controlled trial. Thorax 35:506–512.PubMedGoogle Scholar
  60. 60.
    Burr ML, Neale E, Dean BV, Verrier-Jones ER. (1980), Effect of a change to mitefree bedding on children with mite-sensitive asthma: a controlled trial. Thorax 35:513, 514.PubMedCrossRefGoogle Scholar
  61. 61.
    Mitchell EA, Elliott RB. (1980), Controlled trial of an electrostatic precipitator in childhood asthma. Lancet ii:559–561.CrossRefGoogle Scholar
  62. 62.
    Korsgaard, J. Preventive measures in house-dust allergy. (1982), Am Rev Respir Dis 125:80–84.PubMedGoogle Scholar
  63. 63.
    Korsgaard J. (1983), Preventive measures in mite asthma. A controlled trial. Allergy 38:93–102.PubMedCrossRefGoogle Scholar
  64. 64.
    Murray AB, Ferguson AC. (1983), Dust-free bedrooms in the treatment of asthmatic children with house dust or house dust mite allergy: a controlled trial. Pediatrics 71:418–422.PubMedGoogle Scholar
  65. 65.
    Bowler, SD, Mitchell CA, Miles J. (1985), House dust mite control and asthma: a placebo control trial of cleaning air filtration. Ann Allergy 55:498–500.PubMedGoogle Scholar
  66. 66.
    Walshaw MJ, Evans CC. (1986), Allergen avoidance in house dust mite sensitive adult asthma. Quart J Med 58:199–215.PubMedGoogle Scholar
  67. 67.
    Gillies DRN, Littlewood JM, Sarsfield JK. (1987), Controlled trial of house dust mite avoidance in children with mild to moderate asthma. Clin Allergy 17:105–111.PubMedCrossRefGoogle Scholar
  68. 68.
    Dorward AJ, Colloff MJ, MacKay NS, McSharry CM, Thomson NC. (1988), Effect of house dust, mite avoidance on adult atopic asthma. Thorax 43:98–102.PubMedGoogle Scholar
  69. 69.
    Verrall B, Muir DCF, Wilson WM, Milner R, Johnston M, Dolovitch J. (1988), Laminar flow air cleaner bed attachment: a controlled trial. Ann Allergy 61:117–122.PubMedGoogle Scholar
  70. 70.
    Reiser J, Ingram D, Mitchell EB, Warner JO. (1990), House dust mite allergen levels and an anti-mite mattress spray (natamycin) in the treatment of childhood asthma. Clin Exp Allergy 20:561–567.PubMedCrossRefGoogle Scholar
  71. 71.
    Reisman RE, Mauriello PM, Davis GB, Georgitis JW, DeMasi JM. (1990), A double-blind study of the effectiveness of a high-efficiency particulate air (HEPA) filter in the treatment of patients with perennial allergic rhinitis and asthma. J Allergy Clin Immunol 85:1050–1057.PubMedCrossRefGoogle Scholar
  72. 72.
    Morrow Brown H, Merrett TG. (1991), Effectiveness of an acaricide in management of house dust mite allergy. Ann Allergy 67:25–31.Google Scholar
  73. 73.
    Antonicelli L, Bilo MB, Pucci S, Schou C, Bonifazi F. (1991) Efficacy of an air cleaning device equipped with a high efficiency particulate air filter in house dust mite respiratory allergy. Allergy 46:594–600.PubMedCrossRefGoogle Scholar
  74. 74.
    Ehnert B, Lau-Schadendorf S, Weber A, Buettner P, Schou C, Wahn V. (1993), Reducing domestic exposure to dust mite allergen reduces bronchial hyper-reactivity in sensitive children with asthma. J Allergy Clin Immunol 90:135–138.Google Scholar
  75. 75.
    Huss K, Squire EN, Carpenter GB, Smith LJ, Huss RW, Salata K, et al. (1992), Effective education of adults with asthma who are allergic to dust mites. J Allergy Clin Immunol 89:836–843.PubMedCrossRefGoogle Scholar
  76. 76.
    Dietermann A, Bessot JC, Hoyet C, Ott M, Verot A, Pauli G. (1993), A double-blind, placebo controlled trial of solidified benzyl benzoate applied in dwellings of asthmatic patients sensitive to mites: clinical efficacy and effect on mite allergens. J Allergy Clin Immunol 91:738–746.CrossRefGoogle Scholar
  77. 77.
    Warner JA, Marchant JL, Warner JO. (1993), Double blind trial of ionisers in children with asthma sensitive to the house dust mite. Thorax 48:330–333.PubMedGoogle Scholar
  78. 78.
    Warburton CJ, Niven RMcL, Pickering CAC, Hepworth J, Francis HC. (1994), Domiciliary air filtration units, symptoms and and lung function inatopic asthmatics. Respir Med 88:771–776.PubMedCrossRefGoogle Scholar
  79. 79.
    Marks, GB, Tovey ER, Green W, Shearer M, Salome CM, Woolcock AJ. (1994), House dust mite allergen avoidance: a randomised controlled trial of surface chemical treatment and encasement of bedding. Clin Exp Allergy 24:1078–1083.PubMedCrossRefGoogle Scholar
  80. 80.
    Sette, L, Comis A, Marcucci F, Sensi L, Piacentini GL, Boner AL. (1994), Benzyl bensoate foam: Effect on mite allergens in mattress, serum and nasal secretory IgE to Dermatophagoides pteronyssinus, and bronchial hyperreactivity in children with allergic asthma. Pediatr Pulmonol 18:218–227.PubMedCrossRefGoogle Scholar
  81. 81.
    Huss RW, Huss K, Squire EN, Carpenter GB, Smith LJ, Salata K, Hershey J. (1994), Mite allergen control with acaricide fails. J Allergy Clin Immunol 94:27–31.PubMedCrossRefGoogle Scholar
  82. 82.
    Geller-Bernstein C, Pibourdin JM, Dornelas A, Fondarai J. (1995), Efficacy of the acaricide: Acardust for the prevention of asthma and rhinitis due to dust mite allergy in children. Allergie et Immunologie 27:147–154.PubMedGoogle Scholar
  83. 83.
    Carswell F, Birmingham K, Oliver J, Crewes A, Weeks J. (1996), The respiratory effect of reduction of mite allergen in the bedroom of asthmatic children: a double-blind, controlled trial. Clin Exp Allergy 26:386–396.PubMedCrossRefGoogle Scholar
  84. 84.
    Frederick JM, Warner JO, Jessop WJ, Enander I, Warner JA. (1997), Effect of a bed covering system in children with asthma and house dust mite hypersensitivity. Eur Respir J 10:361–366.PubMedCrossRefGoogle Scholar
  85. 85.
    van der Heide S, Kauffman HF, Dubois AEJ, de Monchy JGR. (1997), Allergen reduction measures in houses of allergic asthmatic patients effects of air cleaners and allergen-impermeable mattress covers. Eur Respir J 10:1217–1223.PubMedCrossRefGoogle Scholar
  86. 86.
    Halken S, Niklassen U, Hansen LG, Nielsen F, Host A, Osterballe O, Veggerby MC, Poulsen LK. (1997), Encasing of mattress in children with asthma and house dust mite allergy. J Allergy Clin Immunol 99:S320.Google Scholar
  87. 87.
    van der Heide S, Kauffman HF, Doubois AEJ, de Monchy JGR. (1997), Allergen avoidance measures in homes of house dust mite allergic asthmatic patients: effects of acaricides and mattress encasing. Allergy 52:921–927.PubMedCrossRefGoogle Scholar
  88. 88.
    Wood RA, Johnson EF, Van Natta ML, Chen PH, Eggleston PA. (1998), A lacebo controlled trial of a HEPA air cleaner in the treatment of cat allergy. Am J Respir Crit Care Med 158:115–120.PubMedGoogle Scholar
  89. 89.
    Roberts DLL. (1984), House dust mite allergen avoidance and atopic dermatitis. Brit J Dermatol 110:735, 736.CrossRefGoogle Scholar
  90. 90.
    August PJ. (1984), House dust mite causes atopic eczema. A preliminary study. Brit J Dermatol 111 (Suppl 26):10, 11.CrossRefGoogle Scholar
  91. 91.
    Colloff MJ, Lever RS, McSharry C. (1989), A controlled trial of house dust mite eradication using natamycin in homes of patients with atopic dermatitis: effect on clinical status and mite populations. Brit J Dermatol 121:199–208CrossRefGoogle Scholar
  92. 92.
    Kniest FM, Young E, Van Praag MCG, Vos H, Kort HSM, Koers WJ, et al. (1991), Clinical evaluation of a double-blind dust-mite avoidance trial with mite-allergic rhinitic patients. Clin Exp Allergy 21:39–47.PubMedCrossRefGoogle Scholar
  93. 93.
    Howarth PH, Lunn A, Tomkins S. (1992), A double-blind, placebo controlled trial of Intervent bedding system in perrential allergic rhinitis (Abstract). J. Allergy Clin Immunol 89:305.Google Scholar
  94. 94.
    Sanda T, Yasue T, Ooashi M, Yasue A. (1992), Effectiveness of house dust-mite allergen avoidance through clean room therapy in patients with atopic dermatitis. J Allergy Clin Immunol 89:653–657.PubMedCrossRefGoogle Scholar
  95. 95.
    Bjornsdottir US, Jakobinudottir S, Runarsdottir V, Blondal Th, Juliusson S. (1997), Environmental control with cat in situ reduces cat allergen (Fel d 1) in house dust samples-but does it alter clinical symptoms? [Abstract]. J Allergy Clin Immunol 99:S389.Google Scholar
  96. 96.
    Tan BB, Weald D, Strickland I, Friedmann PS. (1996), Double blind controlled trial of effects of house dust mite allergen avoidance on atopic dermatitis. Lancet 347:15–18.PubMedCrossRefGoogle Scholar
  97. 97.
    Collof MJ, Ayres J, Carswell F, Howarth PH, Merrett TG, Mitchell EB, et al. (1992), The control of allergens of dust mites and domestic pets: a position paper. Clin Exp Allergy 22 (Suppl 2):1–28.CrossRefGoogle Scholar
  98. 98.
    Platts Mills TAE, Vervloet D, Thomas WR, Aalberse RC, Chapman MD. (1997), Indoor Allergens and Asthma: Report of The Third International Workshop. J Allergy Clin Immunol 100 (6):S1-S21.Google Scholar
  99. 99.
    Anonymous. (1997), The British Guidelines on Asthma Management-1995 Review and Position Statement. Thorax 52 (Suppl 1):S1–S21.Google Scholar
  100. 100.
    Woodcock A, Custovic A. (1998), The role of indoor environment in determining the severity of asthma. Thorax 53 (Suppl 2):S47-S51.PubMedCrossRefGoogle Scholar

Copyright information

© Humana Press Inc. 2000

Authors and Affiliations

  1. 1.North West Lung CentreWythenshawe HospitalManchesterUK

Personalised recommendations